Elspar and Hydrocortisone drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Elspar (asparaginase) and Hydrocortisone (hydrocortisone). Common drug interactions include mucosal inflammation among females and sepsis among males.

The phase IV clinical study analyzes what interactions people have when they take Elspar and Hydrocortisone. It is created by eHealthMe based on reports of 74 people who take the same drugs from the FDA, and is updated regularly.

What is Elspar?

Elspar has active ingredients of asparaginase. eHealthMe is studying from 2,057 Elspar users. Check the latest studies of Elspar.

What is Hydrocortisone?

Hydrocortisone has active ingredients of hydrocortisone. It is often used in addison's disease. eHealthMe is studying from 40,425 Hydrocortisone users. Check the latest studies of Hydrocortisone.



On Jul, 19, 2026

74 people who take Elspar and Hydrocortisone together, and have interactions are studied.

Elspar and Hydrocortisone drug interactions.

What are the common drug interactions of Elspar and Hydrocortisone, by gender? *:

female:

  1. Mucosal inflammation (infection of mucous membrane)
  2. Vomiting
  3. Neutropenia (an abnormally low number of neutrophils)
  4. Pyrexia (fever)
  5. Thrombocytopenia (decrease of platelets in blood)
  6. White blood cell count decreased
  7. Enterocolitis (inflammation of the digestive tract, involving enteritis of the small intestine and colitis of the colon)
  8. Hypoaesthesia (reduced sense of touch or sensation)
  9. Hypokalaemia (low potassium)
  10. Nausea (feeling of having an urge to vomit)

male:

  1. Sepsis (a severe blood infection that can lead to organ failure and death)
  2. Neuropathy peripheral (surface nerve damage)
  3. Pneumonia
  4. Status epilepticus (a life-threatening condition in which the brain is in a state of persistent seizure)
  5. Superior sagittal sinus thrombosis (blood clot in the dural venous sinuses, which drain blood from the brain)
  6. Abnormal behaviour
  7. Antithrombin iii decreased
  8. Areflexia (absence of a reflex)
  9. Blood fibrinogen decreased
  10. Blood osmolarity increased

What are the common drug interactions of Elspar and Hydrocortisone, by age (0-1 to 60+)? *:

0-1:

  1. Diarrhoea
  2. Neutropenia (an abnormally low number of neutrophils)
  3. Pyrexia (fever)
  4. Vomiting
  5. Abdominal distension
  6. Bone marrow depression (decreased ability or inability of the bone marrow to produce blood cells)
  7. Bowel sounds
  8. Bradycardia (abnormally slow heart action)
  9. Bronchopulmonary aspergillosis (lung disorder caused by aspergillus fungi)
  10. Cardio-respiratory arrest (sudden dysfunction of heart and lungs)

2-9:

  1. Chest pressure sensation (feeling of pressure on chest)
  2. Colitis (inflammation of colon)
  3. Cough
  4. Csf culture positive
  5. Depressed level of consciousness
  6. Difficulty in walking
  7. Diplegia (paralysis of corresponding parts on both sides of the body)
  8. Drug hypersensitivity
  9. Enterocolitis infectious
  10. Excessive eye blinking (excessive blinking is dry eyes)

10-19:

  1. Hypoaesthesia (reduced sense of touch or sensation)
  2. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  3. Blood pressure increased
  4. Coagulopathy (blood's ability to clot is impaired)
  5. Heart rate increased
  6. Hypertension (high blood pressure)
  7. Lethargy (tiredness)
  8. Neuropathy peripheral (surface nerve damage)
  9. Pulmonary haemorrhage (acute bleeding from the lung)
  10. Respiratory disorder (respiratory disease)

20-29:

  1. Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
  2. White blood cell count decreased
  3. Enterocolitis infectious
  4. Fluid retention (an abnormal accumulation of fluid in the blood)
  5. Headache (pain in head)
  6. Hypertension (high blood pressure)
  7. Blood alkaline phosphatase increased
  8. Blood bilirubin increased
  9. Cholecystitis (infection of gallbladder)
  10. Gamma-glutamyltransferase increased

30-39:

  1. Csf immunoglobulin increased
  2. Csf protein increased
  3. Febrile neutropenia (fever with reduced white blood cells)
  4. Pneumonia bacterial (pneumonia associated with bacterial infection)
  5. Radiculopathy (a set of conditions in which one or more nerves is affected and does not work properly)
  6. Respiratory tract infection
  7. Sepsis (a severe blood infection that can lead to organ failure and death)
  8. Urinary incontinence (inability to control the flow of urine and involuntary urination)
  9. Urinary retention (the inability to completely or partially empty the bladder)
  10. Urinary tract infection

40-49:

  1. Pneumonia
  2. Denervation atrophy (interruption of the nerve connection to an organ waste away)
  3. Hepatic failure (liver failure)
  4. Jaundice (a yellowish pigmentation of the skin, the conjunctival membranes)
  5. Lividity (a tissue condition of being red or blue because of venous congestion, as in a contusion)
  6. Lumbar radiculopathy (radicular pain in the low back and legs)
  7. Multi-organ failure (multisystem organ failure)
  8. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
  9. Rash erythematous (redness of the skin)
  10. Renal failure (kidney dysfunction)

50-59:

n/a

60+:

  1. Abdominal pain
  2. Ammonia increased
  3. Meningitis (inflammation of the protective membranes covering the brain and spinal cord, known collectively as the meninges)
  4. Pancreatitis (inflammation of pancreas)
  5. Sepsis (a severe blood infection that can lead to organ failure and death)
  6. Bacterial infection
  7. Cardiovascular disorder (heart diseases)
  8. Cellulitis (infection under the skin)
  9. Diverticulitis (digestive disease which involves the formation of pouches (diverticula) within the bowel wall)
  10. Gastrointestinal obstruction

What are the existing conditions these people have? *

  1. Acute Lymphocytic Leukemia (All) (cancer of the white blood cells characterized by excess lymphoblasts): 20 people, 27.03%

* Approximation only. Some reports may have incomplete information.

Do you take Elspar and Hydrocortisone?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Elspar and Hydrocortisone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Elspar:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Hydrocortisone:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Elspar and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Hydrocortisone and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on asparaginase and hydrocortisone (the active ingredients of Elspar and Hydrocortisone, respectively), and Elspar and Hydrocortisone (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: